News - About MEB
12 news items About MEB
Sort by: Date / Relevance
MEB Annual Report 2021: Looking ahead
The coronavirus had a big impact on the year 2021, just like it did in 2020. It made 2021 very special year once again. In the ...
Regulatory Science Magazine on academic drug development
The academic world plays a key role in drug discovery and development. However, bringing drugs to market is challenging and ...
The growing importance of patient registers for the assessment of medicines
Research by the Julius Center (a division of UMC Utrecht), UMC Groningen and the Medicines Evaluation Board reveals that patient ...
Newest issue of Regulatory Science Magazine
Today we have published the latest edition of our online science magazine: Regulatory Science Magazine. This edition contains the ...
Science Policy 2020 - 2024: ‘Regulating with the knowledge of tomorrow’
Today the MEB publishes its Science Policy 2020-2024. Under the heading 'Regulating with the knowledge of tomorrow', eight main ...
MEB Annual Report 2020: Everything changed, everything continues – with a new perspective
The COVID-19 pandemic left an indelible mark on 2020. It would be a year in which everything changed, but in which our regular ...
Regulatory Science Magazine on 25 Years of Pharmacovigilance
The 12th edition of the Medicines Evaluation Board's Regulatory Science Magazine was published today. This issue focuses on 25 ...
MEB Science Day 2021 – Registration is now open!
Earlier the Medicines Evaluation Board announced the next MEB Science Day ‘The evolution of 25 years of Pharmacovigilance’ on 18 ...
Regulatory Science Magazine 11 on monitoring corona vaccines
The eleventh edition of the MEB’s Regulatory Science Magazine brings you interviews with Peter Mol, professor of Drug Regulatory ...
Conclusion of report: paracetamol is safe to use
Patients and consumers can continue to use paracetamol safely in the Netherlands. This is the conclusion of the Netherlands ...